Report of 33 novel AVPR2 mutations and analysis of 117 families with X- linked nephrogenic diabetes insipidus

Journal of the American Society of Nephrology

Volumn 11, Issue 6, 2000, Pages 1044-1054

  Arthus, Marie Françoise ^a   Lonergan, Michèle ^a   Crumley, M Joyce ^d   Naumova, Anna K ^c   Morin, Denis ^e   De Marco, Luiz A ^f   Kaplan, Bernard S ^g,h   Robertson, Gary L ⁱ   Sasaki, Sei ^j   Morgan, Kenneth ^b,c,d   Bichet, Daniel G ^a,k   Fujiwara, T Mary ^b,c,d  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d MONTREAL GENERAL HOSPITAL   (Canada)

^e CNRS   (France)

^f FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^g CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^h UNIVERSITY OF PENNSYLVANIA   (United States)

ⁱ NORTHWESTERN UNIVERSITY   (United States)

^j TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^k HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARGIPRESSIN RECEPTOR; DNA; NUCLEOTIDE;

ARTICLE; DNA SEQUENCE; FAMILY HISTORY; FEMALE; GENE; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; NEPHROGENIC DIABETES INSIPIDUS; NUCLEOTIDE SEQUENCE; PEDIGREE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; X CHROMOSOME INACTIVATION;

EID: 0034121659     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Forssman H: On hereditary diabetes insipidus, with special regard to a sex-linked form. Acta Med Scand 159: 1-196, 1945
2. Bichet DG, Fujiwara TM: Nephrogenic diabetes insipidus. In: The Metabolic and Molecular Bases of Inherited Disease, 8th Ed., edited by Scriver CR, Beaudet AL, Sly WS, Vallee D, Childs B, Vogelstein B, New York, McGraw-Hill, 2000, in press
3. van Lieburg AF, Knoers NVAM, Monnens LAH: Clinical presentation and follow-up of 30 patients with congenital nephrogenic diabetes insipidus. J Am Soc Nephrol 10: 1958-1964, 1999
4. Birnbaumer M, Seibold A, Gilbert S, Ishido M, Barberis C, Antaramian A, Brabet P: Molecular cloning of the receptor for human antidiuretic hormone. Nature 357: 333-335, 1992
5. Oksche A, Rosenthal W: The molecular basis of nephrogenic diabetes insipidus. J Mol Med 76: 326-337, 1998
6. Seibold A, Brabet P, Rosenthal W, Birnbaumer M: Structure and chromosomal localization of the human antidiuretic hormone receptor gene. Am J Hum Genet 51: 1078-1083, 1992
7. Deen PM, Knoers NV: Physiology and pathophysiology of the aquaporin-2 water channel. Curr Opin Nephrol Hypertens 7: 37-42, 1998
8. Bichet DG, Birnbaumer M, Lonergan M, Arthus M-F, Rosenthal W, Goodyer P, Nivet H, Benoit S, Giampietro P, Simonetti S, Fish A, Whitley CB, Jaeger P, Gertner J, New M, DiBona FJ, Kaplan BS, Robertson GL, Hendy GN, Fujiwara TM, Morgan K: Nature and recurrence of AVPR2 mutations in X-linked nephrogenic diabetes insipidus. Am J Hum Genet 55: 278-286, 1994
9. Richards B, Heilig R, Oberlé I, Storjohann L, Horn GT: Rapid PCR analysis of the St14 (DXS52) VNTR. Nucleic Acids Res 19: 1944, 1991
10. Wehnert M, Reiner O, Caskey CT: Four STR polymorphisms map to a 500 kb region between DXS15 and DXS134. Hum Mol Genet 2: 1503, 1993
11. Filosa S, Calabro V, Lania G, Vulliamy TJ, Brancat C, Tagarelli A, Luzzatto L, Martini G: G6PD haplotypes spanning Xq28 from F8C to red/green color vision. Genomics 17: 6-14, 1993
12. Rosenthal W, Seibold A, Antaramian A, Lonergan M, Arthus M-F, Hendy GN, Birnbaumer M, Bichet DG: Molecular identification of the gene responsible for congenital nephrogenic diabetes insipidus. Nature 359: 233-235, 1992
13. Bichet DG, Arthus M-F, Lonergan M, Hendy GN, Paradis AJ, Fujiwara TM, Morgan K, Gregory MC, Rosenthal W, Didwania A, Antaramian A, Birnbaumer M: X-linked nephrogenic diabetes insipidus mutations in North America and the Hopewell hypothesis. J Clin Invest 92: 1262-1268, 1993
14. Holtzman EJ, Harris HWJ, Kolakowski LFJ, Guay-Woodford LM, Botelho B, Ausiello DA: Brief report: A molecular defect in the vasopressin V2-receptor gene causing nephrogenic diabetes insipidus. N Engl J Med 328: 1534-1537, 1993
15. Pan Y, Wilson P, Gitschier J: The effect of eight V2 vasopressin receptor mutations on stimulation of adenylyl cyclase and binding to vasopressin. J Biol Chem 269: 31933-31937, 1994
16. Friedman E, Bale AE, Carson E, Boson WL, Nordenskjold M, Ritzen M, Ferreira PC, Jammal A, De Marco L: Nephrogenic diabetes insipidus: An X chromosome-linked dominant inheritance pattern with a vasopressin type 2 receptor gene that is structurally normal. Proc Natl Acad Sci USA 91: 8457-8461, 1994
17. Wenkert D, Merendino JJ Jr, Shenker A, Thambi N, Robertson GL, Moses AM, Spiegel AM: Novel mutations in the V2 vasopressin receptor gene of patients with X-linked nephrogenic diabetes insipidus. Hum Mol Genet 3: 1429-1430, 1994
18. Sadeghi H, Robertson GL, Bichet DG, Innamorati G, Birnbaumer M: Biochemical basis of partial NDI phenotypes. Mol Endocrinol 11: 1806-1813, 1997
19. Ala Y, Morin D, Mouillac B, Sabatier N, Vargas R, Cotte N, Déchaux M, Antignac C, Arthus M-F, Lonergan M, Turner MS, Balestre M-N, Alonso G, Hibert M, Barberis C, Hendy GN, Bichet DG, Jard S: Functional studies of twelve mutant V2 vasopressin receptors related to nephrogenic diabetes insipidus: Molecular basis of a mild clinical phenotype. J Am Soc Nephrol 9: 1861-1872, 1998
20. Wildin RS, Cogdell DE, Valadez V: AVPR2 variants and V2 vasopressin receptor function in nephrogenic diabetes insipidus. Kidney Int 54: 1909-1922, 1998
21. Collins A, Frezal J, Teague J, Morton NE: A metric map of humans: 23,500 loci in 850 bands. Proc Natl Acad Sci USA 93: 14771-14775, 1996
22. Little S: Amplification-refractory mutation system (ARMS) analysis of point mutations. In: Current Protocols in Human Genetics, edited by Dracopoli NC, Haines JL, Korf BR, Moir DT, Morton CC, Seidman CE, Seidman JG, Smith DR, New York, John Wiley & Sons, 1998, pp 9.8.1-9.8.12
23. Bichet DG, Hendy GN, Lonergan M, Arthus M-F, Ligier S, Pausova Z, Kluge R, Zingg H, Saenger P, Oppenheimer E, Hirsch DJ, Gilgenkrantz S, Salles JP, Oberlé I, Mandel JL, Gregory MC, Fujiwara TM, Morgan K, Scriver CR: X-linked nephrogenic diabetes insipidus: From the ship Hopewell to restriction fragment length polymorphism studies. Am J Hum Genet 51: 1089-1102, 1992
24. Allen RC, Zoghbi HY, Moseley AB, Rosenblatt HM, Belmont JW: Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. Am J Hum Genet 51: 1229-1239, 1992
25. Cooper DN, Krawczak M, Antonarakis SE: The nature and mechanisms of human gene mutation. In: The Metabolic and Molecular Bases of Inherited Disease, 7th Ed., Vol. I, edited by Scriver CR, Beaudet AL, Sly WS, Valle D, New York, McGraw-Hill, 1995, pp 259-291
26. Sinden RR, Wells RD: DNA structure, mutations, and human genetic disease. Curr Opin Biotechnol 3: 612-622, 1992
27. Bode HH, Crawford JD: Nephrogenic diabetes insipidus in North America: The Hopewell hypothesis. N Engl J Med 280: 750-754, 1969
28. Holtzman EJ, Kolakowski LF, O'Brien D, Crawford JD, Ausiello DA: A null mutation in the vasopressin V2 receptor gene (AVPR2) associated with nephrogenic diabetes insipidus in the Hopewell kindred. Hum Mol Genet 2: 1201-1204, 1993
29. Cotton RG, Scriver CR: Proof of "disease causing" mutation. Hum Mutat 12: 1-3, 1998
30. Nomura Y, Onigata K, Nagashima T, Yutani S, Mochizuki H, Nagashima K, Morikawa A: Detection of skewed X-inactivation in two female carriers of vasopressin type 2 receptor gene mutation. J Clin Endocrinol Metab 82: 3434-3437, 1997
31. Willard HF: The sex chromosomes and X chromosome inactivation. In: The Metabolic and Molecular Bases of Inherited Disease, 7th Ed., edited by Scriver CR, Beaudet AL, Sly WS, Valle D, New York, McGraw-Hill, 1995, pp 719-737
32. Heard E, Clerc P, Avner P: X-chromosome inactivation in mammals. Annu Rev Genet 31: 571-610, 1997
33. Busque L, Mio R, Mattioli J, Brais E, Blais N, Lalonde Y, Maragh M, Gilliland DG: Nonrandom X-inactivation patterns in normal females: Lyonization ratios vary with age. Blood 88: 59-65, 1996
34. Puck JM, Willard HF: X inactivation in females with X-linked disease [Editorial]. N Engl J Med 338: 325-328, 1998
35. Schmidt M, Certoma A, Du Sart D, Kalitsis P, Leversha M, Fowler K, Sheffield L, Jack I, Danks DM: Unusual X chromosome inactivation in a mentally retarded girl with an interstitial deletion Xq27: Implications for the fragile X syndrome. Hum Genet 84: 347-352, 1990
36. Clarke JT, Greer WL, Strasberg PM, Pearce RD, Skomorowski MA, Ray PN: Hunter disease (mucopolysaccharidosis type II) associated with unbalanced inactivation of the X chromosomes in a karyotypically normal girl. Am J Hum Genet 49: 289-297, 1991
37. Clarke JT, Wilson PJ, Morris CP, Hopwood JJ, Richards RI, Sutherland GR, Ray PN: Characterization of a deletion at Xq27-q28 associated with unbalanced inactivation of the nonmutant X chromosome. Am J Hum Genet 51: 316-322, 1992
38. Naumova AK, Olien L, Bird LM, Smith M, Verner AE, Leppert M, Morgan K, Sapienza C: Genetic mapping of X-linked loci involved in skewing of X chromosome inactivation in the human. Eur J Hum Genet 6: 552-562, 1998
39. Haldane JBS: The rate of spontaneous mutation of a human gene. J Genet 31: 317-326, 1935
40. Chakravarti A: Fragile X founder effect? [News & Views]. Nat Genet 1: 237-238, 1992
41. Vogel F, Motulsky AG: Human Genetics: Problems and Approaches, 3rd Ed., Berlin, Springer-Verlag, 1997
42. Crow JF: The high spontaneous mutation rate: Is it a health risk? Proc Natl Acad Sci USA 94: 8380-8386, 1997
43. Young ID: Introduction to Risk Calculation in Genetic Counseling, 2nd Ed., Oxford, Oxford University Press, 1999
44. Matsumura Y, Uchida S, Kondo Y, Miyazaki H, Ko SB, Hayama A, Morimoto T, Liu W, Arisawa M, Sasaki S, Marumo F: Overt nephrogenic diabetes insipidus in mice lacking the CLC-K1 chloride channel. Nat Genet 21: 95-98, 1999
45. Morello JP, Salahpour A, Laperrière A, Bernier V, Arthus M-F, Lonergan M, Petäjä-Repo U, Angers S, Morin D, Bichet DG, Bouvier M: Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants. J Clin Invest 105: 887-895, 2000
46. Antonarakis S, and the Nomenclature Working Group: Recommendations for a nomenclature system for human gene mutations. Hum Mutat 11: 1-3, 1998
47. Knoers NV, van den Ouweland AM, Verdijk M, Monnens LA, van Oost BA: Inheritance of mutations in the V2 receptor gene in thirteen families with nephrogenic diabetes insipidus. Kidney Int 46: 170-176, 1994
48. Rocha LJ, Friedman E, Boson W, Moreira A, Figueiredo B, Liberman B, de Lacerda L, Sandrini R, Graf H, Martins S, Punales MK, De Marco L: Molecular analyses of the vasopressin type 2 receptor and aquaporin-2 genes in Brazilian kindreds with nephrogenic diabetes insipidus. Hum Mutat 14: 233-239, 1999
49. Jinnouchi H, Araki E, Miyamura N, Kishikawa H, Yoshimura R, Isami S, Yamaguchi K, Iwamatsu H, Shichiri M: Analysis of vasopressin receptor type II (V2R) gene in three Japanese pedigrees with congenital nephrogenic diabetes insipidus: Identification of a family with complete deletion of the V2R gene. Eur J Endocrinol 134: 689-698, 1996
50. Albertazzi E, Zanchetta D, Barbier P, Faranda S, Frattini A, Vezzoni P, Bettinelli A, Chini B: Nephrogenic diabetes insipidus: Functional analysis of new AVPR2 mutations identified in Italian families. J Am Soc Nephrol 11: 1033-1043, 2000
51. Faa V, Ventruto ML, Loche S, Bozzola M, Podda R, Cao A, Rosatelli MC: Mutations in the vasopressin V2-receptor gene in three families of Italian descent with nephrogenic diabetes insipidus. Hum Mol Genet 3: 1685-1686, 1994
52. Pan Y, Metzenberg A, Das S, Jing B, Gitschier J: Mutations in the V2 vasopressin receptor gene are associated with X-linked nephrogenic diabetes insipidus. Nat Genet 2: 103-106, 1992
53. Shoji Y, Takahashi T, Suzuki Y, Suzuki T, Komatsu K, Hirono H, Shoji Y, Yokoyama T, Kito H, Takada G: Mutational analyses of AVPR2 gene in three Japanese families with X-linked nephrogenic diabetes insipidus: Two recurrent mutations, R137H and delta V278, caused by the hypermutability at CpG dinucleotides. Hum Mutat Suppl 1: S278-S283, 1998
54. Wildin RS, Antush MJ, Bennett RL, Schoof JM, Scott CR: Heterogeneous AVPR2 gene mutations in congenital nephrogenic diabetes insipidus. Am J Hum Genet 55: 266-277, 1994
55. Tsukaguchi H, Matsubara H, Inada M: Expression studies of two vasopressin V2 receptor gene mutations, R202C and 804insG, in nephrogenic diabetes insipidus. Kidney Int 48: 554-562, 1995
56. van den Ouweland AM, Dreesen JC, Verdijk M, Knoers NV, Monnens LA, Rocchi M, van Oost BA: Mutations in the vasopressin type 2 receptor gene (AVPR2) associated with nephrogenic diabetes insipidus. Nat Genet 2: 99-102, 1992
57. Vargas-Poussou R, Forestier L, Dautzenberg MD, Niaudet P, Déchaud M, Antignac C: Mutations in the vasopressin V2 receptor and aquaporin-2 genes in 12 families with congenital nephrogenic diabetes insipidus. J Am Soc Nephrol 8: 1855-1862, 1997
58. Tsukaguchi H, Matsubara H, Aritaki S, Kimura T, Abe S, Inada M: Two novel mutations in the vasopressin V2 receptor gene in unrelated Japanese kindreds with nephrogenic diabetes insipidus. Biochem Biophys Res Commun 197: 1000-1010, 1993